ArriVent BioPharma (AVBP) Q3 2024 Earnings

14AugConfirmed
Q2 2024
Q3 2024
-1.08
-0.93
-0.79
-0.64

Details

Expected EPS
-0.643915
Actual EPS
-0.65
Surprise EPS
-0.01
Surprise Percent
+0.95%

Description

ArriVent BioPharma (AVBP) has reported earnings of -0.65 per share for Q3 2024.

0 Comments

Share your thoughts